Susan H. Alexander is the Executive Vice President and Chief Legal Officer at Biogen Inc., a leading biotechnology company focused on developing innovative therapies for neurological and neurodegenerative diseases. With an extensive legal background, Susan has been instrumental in guiding Biogen through complex legal landscapes and ensuring the company's compliance with industry regulations. Prior to joining Biogen in 2018, she held several high-profile positions, including Senior Vice President and General Counsel at Alexion Pharmaceuticals, where she played a key role in the company's growth and strategic acquisitions. Throughout her career, Susan has demonstrated a strong commitment to advancing the biotechnology industry and has been recognized for her leadership and expertise in the field. She has been actively involved in various industry associations and has served on the board of directors for several organizations, including the Biotechnology Innovation Organization (BIO). Susan's strategic vision and legal acumen have been crucial in navigating Biogen through various challenges and opportunities, such as the development and commercialization of groundbreaking treatments like Spinraza and Aduhelm. As the Chief Legal Officer at Biogen, Susan oversees the company's global legal affairs, including intellectual property, litigation, and corporate governance. Her role is pivotal in ensuring that Biogen maintains its position as a leader in the biotechnology sector while adhering to the highest standards of ethical conduct. Under her leadership, Biogen has continued to foster a culture of innovation and integrity, enabling the company to bring transformative therapies to patients worldwide. Susan's dedication to the company's mission and her ability to navigate complex legal issues have made her an invaluable asset to Biogen and the broader biotechnology community.